Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Natural CapsulesBOM:524654 -0.30%43 PS Ratio is 0.82 as of Aug. 19, 2026, which is 23% below its 10-year median of 1.06. GuruFocus rates BOM:524654 with a GF Score™ of 43/100 and a GF Value™ of ₹313.67 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 950 Drug Manufacturers companies, Natural Capsules ranks better than 79.37% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Natural Capsules's share price is ₹147.70.
Natural Capsules's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹181.14. Hence, Natural Capsules's PS Ratio for today is 0.82.
Good Sign:
Natural Capsules Ltd stock PS Ratio (=0.85) is close to 5-year low of 0.78.
The historical rank and industry rank for Natural Capsules's PS Ratio or its related term are showing as below:
BOM:524654'
s PS Ratio Range Over the Past 10 Years
Min: 0.35 Med: 1.06 Max: 2.95
Current: 0.82
During the past 13 years, Natural Capsules's highest PS Ratio was 2.95. The lowest was 0.35. And the median was 1.06.
BOM:524654's PS Ratio is ranked better than 79.37% of 950
companies
in the Drug Manufacturers industry
Industry Median: 2.33
vs BOM:524654: 0.82
During the past 12 months, the average Revenue per Share Growth Rate of Natural Capsules was 5.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -0.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 4.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 12.00% per year.
During the past 13 years, Natural Capsules's highest 3-Year average Revenue per Share Growth Rate was 34.80% per year. The lowest was -14.00% per year. And the median was 10.25% per year.
Natural Capsules (BOM:524654) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Natural Capsules PS Ratio Related Terms
Natural Capsules PS Ratio Historical Data
* Premium members only.
The historical data trend for Natural Capsules's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Natural Capsules's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Natural Capsules PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Natural Capsules's PS Ratio distribution charts can be found below:
* The bar in red indicates where Natural Capsules's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Natural Capsules's Share Price of today is ₹147.70. Natural Capsules's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹181.14.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Natural Capsules (BOM:524654) has a PS Ratio of 0.82 as of Aug. 19, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Natural Capsules and its competitors. This is 23% below median its historical median of 1.06. Over the past decade, Natural Capsules' PS Ratio has ranged from 0.35 to 2.95. According to the industry distribution chart, Natural Capsules ranks #196 out of 950 companies in the Drug Manufacturers industry, placing it in the top 20.6%.
Is Natural Capsules' PS Ratio too high?
Natural Capsules' current PS Ratio of 0.82 is 23% below median its 10-year median of 1.06. Over the past 10 years, this metric has ranged from a low of 0.35 to a high of 2.95. The Drug Manufacturers industry median PS Ratio is 2.33. Natural Capsules' value of 0.82 is 64.8% below this industry median. Based on the distribution chart, Natural Capsules ranks #196 out of 950 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Natural Capsules has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Natural Capsules' PS Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Natural Capsules ranks #196 out of 950 companies for PS Ratio. This places Natural Capsules in the top 21% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.33. Natural Capsules' value of 0.82 is 64.8% below this benchmark. Historically, Natural Capsules' own PS Ratio has ranged from 0.35 to 2.95 over the past decade. While the company's 10-year median is 1.06 vs. the industry median of 2.33, Natural Capsules has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.33, based on 950 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Natural Capsules's current PS Ratio of 0.82 is 64.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Natural Capsules and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Natural Capsules's current PS Ratio is 0.82, which is 23% below median its own 10-year median of 1.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natural Capsules stock overvalued right now?
Based on GuruFocus' analysis, Natural Capsules (BOM:524654) is currently considered Possible Value Trap. The stock's GF Value™ is ₹313.67, compared to a current price of ₹147.70 — trading 52.9% below its estimated fair value. The current PS Ratio is 0.82, which is 23% below median its 10-year median of 1.06 and 64.8% below the Drug Manufacturers industry median of 2.33. Natural Capsules' overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Natural Capsules (BOM:524654), the current PS Ratio is 0.82 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Natural Capsules (BOM:524654) Overvalued in 2026?
Based on GuruFocus' analysis, Natural Capsules stock appears to be undervalued.
The current stock price of ₹147.70 is trading 52.9% below its estimated GF Value™ of ₹313.67.
GuruFocus considers Natural Capsules to be Possible Value Trap.
Key valuation signals for BOM:524654:
PS Ratio: 0.82 (23% below median its 10-year median of 1.06)
GF Value™: ₹313.67 vs. price of ₹147.70 (52.9% below fair value)
Industry Position: 64.8% below the Drug Manufacturers median (#196 of 950)
No single metric tells the full story. See the BOM:524654 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Natural Capsules Ltd is an India-based company engaged in the manufacturing and selling of empty hard gelatin capsules. The products of the company are Hard gelatin capsule shells, Hard cellulose capsule shells, Shiny gelatin capsule shells, Sweet gelatin capsule shells, Enteric capsule shells, Printed gelatin capsule shells, Vegetarian capsule shells, Fortified gelatin capsule shells, and other capsules. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form, both pharma and nutraceutical products.
43GF Score
Get the complete analysis for BOM:524654
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524654 has been successfully added to your 
